BMEA on Nasdaq
Biomea Fusion, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Research and development | $62.0M | $118.1M | $102.5M |
| General and administrative | $19.3M | $26.0M | $23.6M |
| Impairment of long-lived assets | $2.2M | $0 | $0 |
| Total operating expenses | $83.5M | $144.1M | $126.1M |
| Loss from operations | -$83.5M | -$144.1M | -$126.1M |
| Change in fair value of common warrant liability | $19.9M | $0 | $0 |
| Interest and other income, net | $1.9M | $5.6M | $8.9M |
| Net loss | -$61.8M | -$138.4M | -$117.3M |
| Unrealized gain on investments, net | $1.0K | ||
| Comprehensive loss | -$61.8M | -$138.4M | -$117.3M |
| Net loss per common share, basic | -$1.18 | -$3.83 | -$3.44 |
| Net loss per common share, diluted | -$1.18 | -$3.83 | -$3.44 |
| Weighted-average number of common shares used to compute basic net loss per common share | 52.2M shares | 36.1M shares | 34.1M shares |
| Weighted-average number of common shares used to compute diluted net loss per common share | 52.2M shares | 36.1M shares | 34.1M shares |
Every line of the balance sheet in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $55.8M | $58.3M | $176.9M |
| Prepaid expenses and other current assets | $2.2M | $10.1M | |
| Total current assets | $58.0M | $68.3M | |
| Property and equipment, net | $153.0K | $3.8M | |
| Restricted cash | $369.0K | $369.0K | $370.0K |
| Other non-current assets | $0 | $619.0K | |
| Operating lease right-of-use assets | $0 | $6.9M | |
| Total assets | $58.6M | $79.9M | |
| Accounts payable | $3.2M | $12.9M | |
| Accrued expenses and other current liabilities | $6.4M | $6.7M | |
| Operating lease liabilities, current | $1.5M | $2.1M | |
| Total current liabilities | $11.1M | $21.7M | |
| Operating lease liabilities, non-current | $128.0K | $6.7M | |
| Warrant liability, non-current | $17.8M | $0 | |
| Total liabilities | $29.0M | $28.4M | |
| Common stock, $0.0001 par value; 300,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 72,299,440 and 36,310,713 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | $7.0K | $4.0K | |
| Additional paid-in capital | $478.6M | $438.8M | |
| Accumulated deficit | -$449.0M | -$387.3M | |
| Total stockholders' equity | $29.6M | $51.6M | $169.2M |
| Total liabilities and stockholders' equity | $58.6M | $79.9M | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 300.0M shares | 300.0M shares | |
| Common stock, shares issued | 72.3M shares | 36.3M shares | |
| Common stock, shares outstanding | 72.3M shares | 36.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss | -$61.8M | -$138.4M | -$117.3M |
| Depreciation expense | $1.4M | $1.7M | $1.5M |
| Non-cash operating lease expense | $1.8M | $2.8M | $2.7M |
| Stock-based compensation expense | $9.5M | $19.1M | $14.1M |
| Net amortization of premiums and accretion of discounts on investments | $1.0K | ||
| Change in fair value of warrant liability | -$19.9M | $0 | $0 |
| Impairment of long-lived assets | $2.2M | $0 | $0 |
| Prepaid expenses and other current assets | $7.8M | -$7.7M | $2.5M |
| Other non-current assets | $619.0K | $4.9M | -$2.4M |
| Accounts payable | -$9.7M | $6.1M | $2.6M |
| Accrued expenses and other current liabilities | -$255.0K | -$6.9M | $1.9M |
| Operating lease liabilities | -$2.2M | -$1.5M | -$2.2M |
| Net cash used in operating activities | -$70.4M | -$119.9M | -$96.6M |
| Purchase of property and equipment | -$362.0K | -$3.4M | |
| Maturities of investments | $1.1M | ||
| Net cash (used in) provided by investing activities | -$362.0K | -$2.2M | |
| Proceeds from issuance of common stock under at the market equity offering program, net of offering costs | $4.9M | ||
| Proceeds from issuance of common stock, common warrants and pre-funded warrants, net of offering costs | $62.8M | $161.8M | |
| Proceeds from stock options exercised and purchases under the employee stock purchase plan | $159.0K | $1.7M | $2.0M |
| Net cash provided by financing activities | $67.9M | $1.7M | $163.8M |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -$2.5M | -$118.6M | $65.0M |
| Acquisition of operating lease right-of-use assets | $6.0M | ||
| Acquisition of property and equipment in accounts payable and accrued liabilities | $7.0K | ||
| Remeasurement of operating lease right-of-use assets and lease liability | $5.1M | $5.7M |
Recent filings
- Oct 14, 20268-K
- Sep 22, 20268-K
- Sep 22, 2026424B5
- Aug 5, 20268-K
- Aug 5, 202610-Q
- Jun 12, 20264
- Jun 12, 20264
- Jun 12, 20264
- Jun 12, 20264
- Jun 11, 20268-K
- May 11, 20268-K
- May 11, 202610-Q
- Apr 28, 20268-K
- Apr 27, 2026ARS
- Apr 27, 2026DEF 14A
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9